IBM analysts lift targets after Q3 beat as retail attention spikes

IBM jumped 3.9% on October 21 after reporting Q3 results, and the post-earnings analyst reaction on October 22 has been swift. At least six firms raised their price targets on the same day, while retail attention hit 2.93 standard deviations above its 90-day average, per Wikipedia views and ORTEX stock page traffic data.

Wall Street lifts the bar

Barclays analyst Raimo Lenschow raised his target to $277 from $262, keeping an Overweight rating. JP Morgan's Brian Essex went to $269 from $250, also Overweight. Stifel moved to $260 from $235 with a Buy. Baird raised to $260 from $230, maintaining Neutral. Susquehanna lifted to $256 from $235, also Neutral. RBC Capital reiterated Outperform at $270.

The consensus target now stands at $257.22. IBM closed at $251.46 on October 21, leaving the mean target roughly 2% above the current price. The range of active targets runs from Morgan Stanley's $238 to Barclays' $277, so the street is not uniformly bullish, but the direction of revisions on the day is one-sided upward.

Among IBM's closest correlated peers, KD gained 21.7% over the past week and DXC rose 20.4%. IBM's own 10.3% weekly gain puts it in the middle of the peer group on price momentum. UIS added 10.2% and GIB.A 8.5%. IBM carries less short positioning than most of these names, a factor that has kept it insulated from momentum-driven selling in recent weeks.

Retail attention surges post-earnings

ORTEX alt data shows IBM's retail attention reading at 2.93 standard deviations above its 90-day average as of October 22. The measure combines daily English Wikipedia article views and distinct ORTEX stock page visitors, each on a log scale. This is an attention signal, not a revenue or earnings indicator, but the spike is consistent with the post-earnings news flow drawing in a broader audience.

Short positioning and borrowing costs

Short interest stands at 23.7 million shares, or 2.5% of the free float, as of October 21. That is a low absolute level. The lending market remains exceptionally loose. Availability is 7,730% of short interest, meaning there are dozens of lendable shares for every one already borrowed. The cost to borrow edged back to 0.50% on October 21 after spiking to 0.56% on October 16. That spike, and the 11% one-month rise in shares short, both predated the earnings print. With results now out and analysts revising higher, the near-term catalyst that drove the pre-earnings short build has passed.

The ORTEX short score sits at 34.8, up from 32.2 two weeks ago, a steady climb but still well below levels that would signal meaningful bearish conviction.

---

What to watch: Whether the consensus target migrates toward the top of the range (Barclays at $277, JP Morgan at $269) or firms holding Neutral adjust their $238 to $260 band, as that spread captures the remaining uncertainty around IBM's full-year revenue growth guidance.